TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
BioNordika (Sweden) AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 40,521 | 35,904 | 41,494 |
Financial expenses | 0 | 0 | 1 |
Earnings before taxes | 4,284 | 4,863 | 7,405 |
EBITDA | 4,300 | 5,028 | 7,595 |
Total assets | 10,432 | 13,408 | 16,856 |
Current assets | 9,293 | 12,931 | 16,429 |
Current liabilities | 6,982 | 10,150 | 13,320 |
Equity capital | 3,450 | 3,258 | 3,537 |
- share capital | 67 | 67 | 73 |
Employees (average) | 14 | 13 | 12 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 33.1% | 24.3% | 21.0% |
Turnover per employee | 2,894 | 2,762 | 3,458 |
Profit as a percentage of turnover | 10.6% | 13.5% | 17.8% |
Return on assets (ROA) | 41.1% | 36.3% | 43.9% |
Current ratio | 133.1% | 127.4% | 123.3% |
Return on equity (ROE) | 124.2% | 149.3% | 209.4% |
Change turnover | 4,432 | -2,229 | 1,874 |
Change turnover % | 12% | -6% | 5% |
Chg. No. of employees | 1 | 1 | 2 |
Chg. No. of employees % | 8% | 8% | 20% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.